Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma.
about
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Benralizumab: From the Basic M ...... of Severe Eosinophilic Asthma.
@en
Benralizumab: From the Basic M ...... of Severe Eosinophilic Asthma.
@nl
type
label
Benralizumab: From the Basic M ...... of Severe Eosinophilic Asthma.
@en
Benralizumab: From the Basic M ...... of Severe Eosinophilic Asthma.
@nl
prefLabel
Benralizumab: From the Basic M ...... of Severe Eosinophilic Asthma.
@en
Benralizumab: From the Basic M ...... of Severe Eosinophilic Asthma.
@nl
P2093
P2860
P921
P356
P1476
Benralizumab: From the Basic M ...... of Severe Eosinophilic Asthma.
@en
P2093
Cecilia Calabrese
Corrado Pelaia
Eugenio Garofalo
Maria Teresa Busceti
Nicola Lombardo
Rosa Terracciano
P2860
P304
P356
10.1155/2018/4839230
P407
P5008
P577
2018-05-10T00:00:00Z